Literature DB >> 16721110

Management of fetal growth restriction: an evidence-based approach.

Dev Maulik1.   

Abstract

This review provides an evidence-based approach to the management of fetal growth restriction (FGR). The management consists of the following components: appropriate fetal surveillance, timely intervention, and selective etiological management. Umbilical arterial (UA) Doppler sonography is the primary test. Supplementary tests include nonstress test (NST), amniotic fluid assessment, biophysical profile (BPP), and selective venous Doppler sonography. Ominous signs include UA absent or reverse end-diastolic flow, non-assuring NST, low BPP, and abnormal fetal venous flow patterns. An evidence-based clinical management guideline is included and individualization of care is recommended.

Mesh:

Year:  2006        PMID: 16721110     DOI: 10.1097/00003081-200606000-00013

Source DB:  PubMed          Journal:  Clin Obstet Gynecol        ISSN: 0009-9201            Impact factor:   2.190


  4 in total

1.  Methodological quality of test accuracy studies included in systematic reviews in obstetrics and gynaecology: sources of bias.

Authors:  Rachel K Morris; Tara J Selman; Javier Zamora; Khalid S Khan
Journal:  BMC Womens Health       Date:  2011-03-22       Impact factor: 2.809

Review 2.  Customised versus population-based growth charts as a screening tool for detecting small for gestational age infants in low-risk pregnant women.

Authors:  Angela E Carberry; Adrienne Gordon; Diana M Bond; Jon Hyett; Camille H Raynes-Greenow; Heather E Jeffery
Journal:  Cochrane Database Syst Rev       Date:  2014-05-16

Review 3.  Diagnosis and management of fetal growth restriction.

Authors:  Jacqueline E A K Bamfo; Anthony O Odibo
Journal:  J Pregnancy       Date:  2011-04-13

Review 4.  Planned early delivery versus expectant management of the term suspected compromised baby for improving outcomes.

Authors:  Diana M Bond; Adrienne Gordon; Jon Hyett; Bradley de Vries; Angela E Carberry; Jonathan Morris
Journal:  Cochrane Database Syst Rev       Date:  2015-11-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.